Stoke Therapeutics
STOK
Stoke Therapeutics (STOK) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $40.00 | Aug 21, 2026 |
| Chardan Capital | Maintained | Buy | $35.00 | Aug 4, 2026 |
| Canaccord Genuity | Maintained | Buy | $58.00 from $60.00 | Aug 4, 2026 |
| Wedbush | Maintained | Outperform | $40.00 from $38.00 | Aug 4, 2026 |
| Guggenheim | Maintained | Buy | $60.00 | Aug 4, 2026 |
| Goldman Sachs | Initiated Coverage | Buy | $44.00 | Jul 13, 2026 |
| BTIG | Maintained | Buy | $39.00 | May 11, 2026 |
| Canaccord Genuity | Maintained | Buy | $60.00 from $36.00 | Mar 20, 2026 |
| BTIG | Maintained | Buy | $39.00 | Mar 19, 2026 |
| Chardan Capital | Maintained | Buy | $35.00 | Mar 18, 2026 |
| Wedbush | Maintained | Outperform | $38.00 from $36.00 | Mar 18, 2026 |
| Needham | Maintained | Buy | $40.00 from $35.00 | Mar 17, 2026 |
| Wedbush | Maintained | Outperform | $38.00 from $36.00 | Mar 17, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $40.00 | Feb 24, 2026 |
| Wedbush | Maintained | Outperform | $36.00 from $32.00 | Jan 12, 2026 |
| Canaccord Genuity | Maintained | Buy | $36.00 from $28.00 | Jan 5, 2026 |
| Chardan Capital | Maintained | Buy | $35.00 from $24.00 | Jan 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 from $35.00 | Dec 15, 2025 |
| BTIG | Maintained | Buy | $39.00 | Nov 5, 2025 |
| Wedbush | Maintained | Outperform | $32.00 from $22.00 | Nov 5, 2025 |
Frequently asked questions
What is the latest analyst rating on STOK?
On Aug 21, 2026, JP Morgan maintained Stoke Therapeutics at Overweight with a price target of $40.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.